Ovid Therapeutics annual operating margin
2020
2021
2022
2023
2024
2025
Ovid Therapeutics's operating margin was −585.20% for fiscal 2025.
View full Ovid Therapeutics company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −585.20% | +10348.54 pp |
| 2024 | 2024-12-31 | −10,933.75% | +4188.96 pp |
| 2023 | 2023-12-31 | −15,122.70% | −11426.27 pp |
| 2022 | 2022-12-31 | −3,696.44% | −3756.05 pp |
| 2021 | 2021-12-31 | 59.61% | +705.00 pp |
| 2020 | 2020-12-31 | −645.40% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −2,141.61% | +7512.24 pp |
| Q4 2025 | 2025-12-31 | −1,712.12% | +12399.73 pp |
| Q3 2025 | 2025-09-30 | −9,487.12% | −1842.03 pp |
| Q2 2025 | 2025-06-30 | −80.88% | +12059.35 pp |
| Q1 2025 | 2025-03-31 | −9,653.85% | +2114.40 pp |
| Q4 2024 | 2024-12-31 | −14,111.84% | −1303.39 pp |
| Q3 2024 | 2024-09-30 | −7,645.09% | +3390.69 pp |
| Q2 2024 | 2024-06-30 | −12,140.24% | +6755.76 pp |
| Q1 2024 | 2024-03-31 | −11,768.24% | +10795.39 pp |
| Q4 2023 | 2023-12-31 | −12,808.45% | +13494.30 pp |
| Q3 2023 | 2023-09-30 | −11,035.78% | +104293.49 pp |
| Q2 2023 | 2023-06-30 | −18,896.00% | −17770.53 pp |
| Q1 2023 | 2023-03-31 | −22,563.64% | −22648.36 pp |
| Q4 2022 | 2022-12-31 | −26,302.75% | −26065.50 pp |
| Q3 2022 | 2022-09-30 | −115,329.27% | — |
| Q1 2022 | 2022-03-31 | −1,125.47% | — |
| Q1 2021 | 2021-03-31 | 84.73% | — |
| Q3 2020 | 2020-09-30 | −237.25% | — |
Over the last five reported fiscal years, Ovid Therapeutics's operating margin increased from −645.40% to −585.20%, a change of +60.19 percentage points. The latest reported quarter, Q2 2026, shows −2,141.61%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ovid Therapeutics filings at SEC.gov ↗